Lifesci Capital Has Negative Outlook of AVDL FY2024 Earnings
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) – Investment analysts at Lifesci Capital decreased their FY2024 earnings per share (EPS) estimates for Avadel Pharmaceuticals in a research report issued on Thursday, January 9th. Lifesci Capital analyst M. Belghiti now anticipates that the company will post earnings per share of ($0.46) for the year, down from […]
More Stories
Who is Milo Manheim Dating? Know About the ‘Tangled’ Lead Character
Milo Manheim, the actor, rose to fame from the Zombies franchise on Disney television films. His other films, like Journey...
Kathryn Morris Net Worth, Career, and Life After Cold Case
Starting from a simple life to becoming a name that everyone knows and remembers, Kathryn Morris has come a long way....
Gmail Introduces One of the Biggest Changes Since Its Launch Decades Ago!
Google has completely integrated its Gemini AI into Gmail, launching new features like AI-powered email summaries, personalized replies, and a...
EU Hosts Emergency Meeting in Response to Trump’s Tariffs Over Greenland
By Jacob Burg The European Union called an emergency meeting of ambassadors from the bloc’s 27 nations on Jan. 18...
Minnesota Gov. Tim Walz Mobilizes National Guard Amid Anti-ICE Protests
By Jacki Thrapp Minnesota Gov. Tim Walz said he has mobilized his state’s National Guard on Jan. 17 and will...
California AG Sends Cease-and-Desist Letter to Musk’s xAI Over Nonconsensual Explicit Images
By Kimberly Hayek California’s top law enforcement official on Friday ordered Elon Musk’s artificial intelligence company xAI to stop the...